Alvotech (ALVO) Competitors $8.72 -0.03 (-0.34%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$8.76 +0.04 (+0.52%) As of 10/17/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO vs. ELAN, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, RYTM, CRSP, and GRFSShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. Its Competitors Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Abivax Avidity Biosciences Cytokinetics Merus Rhythm Pharmaceuticals CRISPR Therapeutics Grifols Alvotech (NASDAQ:ALVO) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment. Which has more volatility & risk, ALVO or ELAN? Alvotech has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Do analysts rate ALVO or ELAN? Alvotech presently has a consensus price target of $14.00, indicating a potential upside of 60.55%. Elanco Animal Health has a consensus price target of $19.14, indicating a potential downside of 10.65%. Given Alvotech's higher possible upside, equities research analysts plainly believe Alvotech is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alvotech 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.80Elanco Animal Health 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.91 Does the media refer more to ALVO or ELAN? In the previous week, Elanco Animal Health had 1 more articles in the media than Alvotech. MarketBeat recorded 8 mentions for Elanco Animal Health and 7 mentions for Alvotech. Alvotech's average media sentiment score of 0.77 beat Elanco Animal Health's score of 0.64 indicating that Alvotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, ALVO or ELAN? Elanco Animal Health has higher revenue and earnings than Alvotech. Elanco Animal Health is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$491.98M5.34-$231.86M$0.2337.91Elanco Animal Health$4.48B2.37$338M$0.8624.91 Do institutionals and insiders have more ownership in ALVO or ELAN? 97.5% of Elanco Animal Health shares are owned by institutional investors. 0.5% of Alvotech shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is ALVO or ELAN more profitable? Alvotech has a net margin of 11.26% compared to Elanco Animal Health's net margin of 9.68%. Elanco Animal Health's return on equity of 7.04% beat Alvotech's return on equity.Company Net Margins Return on Equity Return on Assets Alvotech11.26% -38.36% 9.28% Elanco Animal Health 9.68%7.04%3.45% SummaryElanco Animal Health beats Alvotech on 11 of the 17 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVO vs. The Competition Export to ExcelMetricAlvotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.63B$3.44B$6.21B$10.54BDividend YieldN/A2.28%5.70%4.81%P/E Ratio37.9123.1685.7027.13Price / Sales5.34448.62581.43177.30Price / CashN/A46.9237.1060.81Price / Book-6.3610.4112.236.52Net Income-$231.86M-$52.77M$3.33B$276.93M7 Day Performance5.83%2.31%1.17%1.93%1 Month Performance10.66%12.59%6.85%2.19%1 Year Performance-29.34%11.18%58.93%34.62% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOAlvotech3.71 of 5 stars$8.72-0.3%$14.00+60.6%-29.3%$2.63B$491.98M37.911,032Analyst ForecastELANElanco Animal Health2.5761 of 5 stars$20.04+1.4%$19.14-4.5%+65.2%$9.82B$4.44B23.309,000News CoverageAnalyst RevisionVRNAVerona Pharma PLC American Depositary Share1.5429 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.4105 of 5 stars$48.75+1.1%$74.64+53.1%+7.3%$9.02B$11.58M-10.83250News CoverageAnalyst ForecastInsider TradeGap UpABVXAbivax3.4891 of 5 stars$95.63+2.0%$114.25+19.5%+787.4%$7.30BN/A0.0061Short Interest ↓RNAAvidity Biosciences2.5512 of 5 stars$48.96-1.6%$68.32+39.5%-5.1%$7.26B$10.90M-13.75190News CoverageInsider TradeCYTKCytokinetics3.8472 of 5 stars$59.59-0.7%$76.64+28.6%+6.3%$7.18B$18.47M-11.68250Trending NewsInsider TradeMRUSMerus1.3958 of 5 stars$94.85+0.5%$93.12-1.8%+80.1%$7.14B$36.13M-17.2537Short Interest ↓RYTMRhythm Pharmaceuticals2.874 of 5 stars$100.770.0%$106.64+5.8%+116.9%$6.70B$130.13M-33.48140News CoverageAnalyst ForecastCRSPCRISPR Therapeutics2.2308 of 5 stars$68.29-6.5%$71.71+5.0%+41.4%$6.65B$37.31M-12.58460Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionGRFSGrifols3.7479 of 5 stars$9.45+1.4%$10.30+9.0%+11.6%$6.41B$7.81B8.0823,822 Related Companies and Tools Related Companies ELAN Competitors VRNA Competitors RVMD Competitors ABVX Competitors RNA Competitors CYTK Competitors MRUS Competitors RYTM Competitors CRSP Competitors GRFS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVO) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALVO Stock Alerts